Johnson Investment Counsel’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
4,068
-362
-8% -$41.8K ﹤0.01% 618
2026
Q1
$529K Sell
4,430
-1,225
-22% -$161K ﹤0.01% 570
2025
Q4
$770K Sell
5,655
-121
-2% -$17.4K 0.01% 454
2025
Q3
$852K Sell
5,776
-847
-13% -$117K 0.01% 459
2025
Q2
$857K Sell
6,623
-28
-0.4% -$3.39K 0.01% 431
2025
Q1
$795K Buy
6,651
+5
+0.1% +$620 0.01% 438
2024
Q4
$771K Sell
6,646
-447
-6% -$56.5K 0.01% 441
2024
Q3
$958K Buy
7,093
+2,001
+39% +$268K 0.01% 396
2024
Q2
$691K Sell
5,092
-69
-1% -$9.39K 0.01% 434
2024
Q1
$667K Sell
5,161
-1,683
-25% -$203K 0.01% 440
2023
Q4
$783K Sell
6,844
-380
-5% -$37.9K 0.01% 402
2023
Q3
$658K Buy
7,224
+2,600
+56% +$268K 0.01% 410
2023
Q2
$521K Sell
4,624
-97
-2% -$10.3K 0.01% 466
2023
Q1
$494K Sell
4,721
-1,117
-19% -$117K 0.01% 462
2022
Q4
$646K Sell
5,838
-140
-2% -$14.7K 0.01% 412
2022
Q3
$522K Sell
5,978
-246
-4% -$22.4K 0.01% 431
2022
Q2
$487K Sell
6,224
-2,180
-26% -$180K 0.01% 451
2022
Q1
$717K Sell
8,404
-822
-9% -$78.8K 0.01% 403
2021
Q4
$1.11M Sell
9,226
-1,203
-12% -$149K 0.01% 336
2021
Q3
$1.29M Sell
10,429
-6,276
-38% -$808K 0.02% 297
2021
Q2
$2M Sell
16,705
-3,078
-16% -$352K 0.03% 214
2021
Q1
$2.08M Sell
19,783
-7,970
-29% -$808K 0.03% 203
2020
Q4
$2.83M Sell
27,753
-4,939
-15% -$464K 0.05% 162
2020
Q3
$2.75M Sell
32,692
-18,096
-36% -$1.41M 0.05% 159
2020
Q2
$3.3M Sell
50,788
-562,918
-92% -$37.2M 0.07% 149
2020
Q1
$47.4M Buy
613,706
+73,379
+14% +$5.78M 1.05% 26
2019
Q4
$42.6M Buy
540,327
+24,694
+5% +$1.92M 0.8% 41
2019
Q3
$41.1M Buy
515,633
+4,334
+0.8% +$341K 0.82% 39
2019
Q2
$42.8M Buy
511,299
+14,499
+3% +$1.16M 0.88% 36
2019
Q1
$39.3M Buy
496,800
+94,409
+23% +$6.89M 0.84% 36
2018
Q4
$26.8M Buy
402,391
+387,519
+2,606% +$26.8M 0.65% 45
2018
Q3
$1.19M Buy
+14,872
New +$1.11M 0.03% 297

Other funds holding XYL

Johnson Investment Counsel's XYL Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Xylem (XYL) stake by 8.2% in Q2 2026, selling an estimated $41.8K and leaving 4,068 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Johnson Investment Counsel first reported a position in XYL in Q3 2018 and has held it in 32 quarters since. The position peaked at $47.4M in Q1 2020. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Johnson Investment Counsel held 4,068 shares of Xylem worth $481K as of Q2 2026.
  • Johnson Investment Counsel sold 362 Xylem shares in Q2 2026, an estimated $41.8K.
  • Xylem made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #618 holding.
  • Johnson Investment Counsel first reported a position in Xylem in Q3 2018 and has held it in 32 quarters since.
  • Johnson Investment Counsel's Xylem position peaked at $47.4M in Q1 2020.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.